35 min listen
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.
ratings:
Length:
67 minutes
Released:
May 23, 2022
Format:
Podcast episode
Description
As COVID-19 cases climb yet again, the Business of Biotech catches up with Tonix Pharmaceuticals CEO Seth Lederman, M.D. for a conversation on his company's multi-pronged strategy to advance vaccine and therapeutic candidates to address the disease and its variants. In addition to sharing on his journey from academia to industry, Dr. Lederman discusses his company's approach to grabbing its share of the highly competitive, and highly lucrative, vaccine market.
Released:
May 23, 2022
Format:
Podcast episode
Titles in the series (100)
Summer Sessions 1: Ivor Macleod brings big-league finance experience to an emerging biotech by Business Of Biotech